Hereditary Leiomyomatosis and Renal Cell Cancer


Read the full story: http://irp.nih.gov/our-researc....h/research-in-action
W. Marston Linehan, M.D., investigates kidney cancer gene pathways to find new treatment strategies. In this video, he discusses hereditary leiomyomatosis and renal cell cancer (HLRCC) with Eric, a patient participating in research at the NIH Clinical Center. Dr. Linehan is Chief of the Urologic Oncology Branch in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI).


In today's #KidneyCANDID, Dr. Brandon Manley from the Moffitt Cancer Center in Tampa, Florida, discusses hereditary renal cancers. The most common is von Hippel-Lindau syndrome, though it is not the only hereditary #kidneycancer. Dr. Manley offers advice for understanding the diagnosis, finding support in patient groups, and connecting with genetic specialists to understand the impact of your diagnosis on family members.
If you're facing kidney cancer, you're not alone. KidneyCAN has an entire community of patients and caregivers who can talk to you about your experiences and help connect you to expert care. Check out our Patient Resource Center and patient education events at www.kidneycan.org.
Have a KidneyCANDID topic you'd like to see us tackle? Let us know by emailing info@kidneycan.org with KidneyCANDID Topic in the subject line.
—————————————————————————
KidneyCAN works to accelerate cures for kidney cancer by providing patient support and education, encouraging enrollment in clinical trials, advocating for research funding from Congress, and sponsoring collaborative efforts between researchers and medical communities.
To learn more about KidneyCAN: https://kidneycan.org
Support our work: https://kidneycan.org/donate